文献速递间质性肺疾病

经支气管肺冷冻活检对特发性肺纤维化多学科诊断的预后价值:一项回顾性验证研究

Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study.
PubMed 文献 · Lancet Respir Med · 2020-01-01

该单中心回顾性研究纳入426例接受经支气管肺冷冻活检(TBLC)或外科肺活检(SLB)的间质性肺疾病患者,评估基于TBLC的多学科团队(MDT)诊断区分特发性肺纤维化(IPF)与其他间质性肺疾病的预后意义。

要点

  • 基于TBLC的MDT诊断区分IPF与其他ILD具有明确预后意义。
  • TBLC诊断IPF患者5年无移植生存率68%,非IPF者93%。
  • 多变量分析校正后,IPF诊断仍与更差生存显著相关。

核心结论

  • TBLC在多学科诊断中区分IPF与其他间质性肺疾病,具有明确的预后价值。

研究设计与样本

  • 单中心、回顾性、研究者发起的比较研究,纳入连续患者。
  • 共评估500例连续病例,最终纳入426例,其中266例接受TBLC,160例接受SLB。

主要发现

  • 189例患者诊断为IPF,143例为其他纤维化间质性肺疾病,94例为非纤维化间质性肺疾病。

临床怎么用

  • 在间质性肺疾病多学科诊断中,TBLC结果有助于区分IPF与其他间质性肺疾病并判断预后。

局限性

  • 单中心回顾性研究,TBLC与SLB患者基线特征存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transbronchial lung cryobiopsy (TBLC) has been introduced recently in the diagnosis of interstitial lung diseases. We aimed to evaluate the prognostic significance of the distinction between idiopathic pulmonary fibrosis and other interstitial lung diseases with the use of TBLC data in multidisciplinary team (MDT) diagnosis. METHODS: In this single-centre, retrospective, investigator-initiated comparative study, we evaluated consecutive patients without a definite usual interstitial pneumonia pattern on high-resolution CT, who presented to the GB Morgagni Hospital (Forlì, Italy), and who underwent TBLC (Jan 1, 2011, to Dec 31, 2014) or surgical lung biopsy (SLB; Jan 1, 2002, to Dec 31, 2016). Three pathologists reviewed the specimens, masked to clinical information. MDT evaluation was done before and after biopsy. The primary endpoint was the prognostic significance of the MDT diagnostic separation between idiopathic pulmonary fibrosis and other interstitial lung diseases in patients undergoing TBLC. Mortality was evaluated by means of Cox regression analysis. FINDINGS: We evaluated 500 consecutive cases, 426 of which were included: 266 had TBLC and 160 had SLB. 189 patients had idiopathic pulmonary fibrosis, 143 had other fibrotic interstitial lung diseases, and 94 had non-fibrotic interstitial lung diseases. Patients undergoing TBLC had more comorbidities and better preserved lung function compared with those undergoing SLB; among patients with a final MDT diagnosis of idiopathic pulmonary fibrosis, patients undergoing TBLC were older, had more comorbidities, and had a different post-biopsy treatment profile than those who received SLB. The distinction between idiopathic pulmonary fibrosis and other interstitial lung diseases made by MDT diagnosis on the basis of TBLC biopsy had clear prognostic significance, with a 5-year transplant-free survival of 68% (95% CI 57-76) in patients with an MDT idiopathic pulmonary fibrosis diagnosis based on TBLC compared with 93% (87-96) in patients without an idiopathic pulmonary fibrosis diagnosis based on TBLC (hazard ratio 5·28, 95% CI 2·72-10·04; p<0·0001). This distinction remained statistically significant in a multivariate analysis controlling for age, sex, smoking status, comorbidities, pulmonary function, and high-resolution CT patterns (p=0·02). INTERPRETATION: TBLC makes an important diagnostic contribution in interstitial lung disease, on the basis of the prognostic distinction between idiopathic pulmonary fibrosis and other interstitial lung diseases when TBLC findings are included in multidisciplinary diagnosis. FUNDING: None.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Tomassetti S, Ravaglia C, Wells AU, et al. Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study. Lancet Respir Med. 2020. PMID: 32763205. doi:10.1016/S2213-2600(20)30122-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。